Drug Shortage Report for SHINGRIX

Last updated on 2022-09-09 History
Report ID 156847
Drug Identification Number 02468425
Brand name SHINGRIX
Common or Proper name Herpes Zoster vaccine
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN
Strength(s) 50MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10's
ATC code J07BK
ATC description
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-03-16
Estimated end date 2022-09-14
Actual end date 2022-09-08
Shortage status Resolved
Updated date 2022-09-09
Company comments Limited supply available for public programs. Supply unavailable for the private market. SHINGRIX is available to order in packages of 1.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2022-09-09 English Compare
v10 2022-09-08 French Compare
v9 2022-09-08 English Compare
v8 2022-08-19 French Compare
v7 2022-08-19 English Compare
v6 2022-08-19 French Compare
v5 2022-08-19 English Compare
v4 2022-03-21 French Compare
v3 2022-03-21 English Compare
v2 2022-03-17 French Compare
v1 2022-03-17 English Compare

Showing 1 to 11 of 11